This site is intended for healthcare professionals only
LoginRegister
Dont throw in the bin, please flush it! CDSCO dictum for these 17 medicinesWockhardt sells USFDA-approved migraine tablet to Senores Pharma
Morepen Labs Naresh Sharma resigns as Vice President - Operations (API)Morepen Labs Naresh Sharma resigns as Vice President - Operations (API)
Roche to proceed with Phase III development of Prasinezumab in early-stage Parkinsons diseaseRoche launches Elecsys PRO-C3 test for liver fibrosis
Eli Lilly collaborate with API to launch Obesity Gurukul for obesity care in IndiaCDSCO Panel approves Eli Lilly proposal to Increase patients number from India 37 to 57 for ...
Sanofi Sarclisa recommended for EU approval by CHMP for transplant-eligible newly diagnosed multiple myelomaSanofi Healthcare India Gets CDSCO Panel Nod To study SAR441566
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, DapagliflozinSubstandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation
Star Health names Rajeev Kher as Chairperson of BoardStar Health names Rajeev Kher as Chairperson of Board
Kerala Races to Audit Hospital Buildings for Structural SafetyShilpa Biologics Dharwad site gets European GMP certification
Biocon, NCSM partnerBiocon Biologics secures multiple market access agreements in US for Yesintek
WHO plans to back use of weight-loss drugs for adults globallyWHO to back use of weight-loss drugs as obesity treatment in adults
Batch of Telma AM earlier classified as NSQ now flagged as SpuriousBatch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious
AstraZeneca Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancerCDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study
X